Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bora has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
ERT announced a preferred partnership with neuroscience technology company, Cogstate.
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
Novavax and FUJIFILM Diosynth Biotechnologies has announced an agreement to manufacture bulk drug substance for NVX-CoV2373, Novavax' COVID-19 vaccine candidate.
read more
MediciNova announced an agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine using BC-PIV, a human parainfluenza virus type 2 vector.
read more
To reduce the risk of death from opioid overdose, the FDA is making the following recommendations about the opioid reversal medicine, naloxone.
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
Exonbio has launched the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
JanOne has received confirmation from the FDA for the IND sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience.
read more
Protalix BioTherapeutics has entered into a non-binding term sheet with SarcoMed USA Inc.
read more
The Menarini Group and Radius Health announced the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.
read more
Element Materials Technology has acquired pharmaceutical testing business, Analytical Lab Group (ALG) from Thompson Street Capital Partners.
read more
Centogene announced they will collaborate exclusively to initiate the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project – starting with Epilepsy as the first indication.
read more
Sterling Pharma Solutions has signed an agreement with Moleculin Biotech to support the company’s expanded development efforts for its potential COVID-19 treatment, WP1122.
read more